Scientific Education Support
MPN Hub
The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.
N'hésitez pas à visiter le site du podcast et à soutenir son créateur : mpn-hub.com
Auteur
Scientific Education Support
Catégorie
Site du podcast
Dernier épisode
7 juil. 2026
Où écouter ?
Les podcasts dans l'appli Replaio Radio Bientôt disponibleLes podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts
Épisodes
Does interferon alpha prolong survival and prevent progression in patients with PV? 15.12.2020 5:34
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to Ghaith Abu-Zeinah, Weill Cornell Medicine, New York, US. We asked, Does interferon alpha prolong survival and prevent progression in patients with polycythemia vera (PV)? PV is a disease associated with shorter survival due to short-term complications, such as thrombosis, and long-term complica...
What do we know about the outcome of concomitant MPN and COVID-19? 06.11.2020 17:43
During the First Annual Texas Virtual MPN Workshop, the MPN Hub spoke to our Steering Committee members Laura Michaelis, Medical College of Wisconsin, Milwaukee , US, and Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT. We asked, What do we know about the outcome of concomitant MPN and COVID-19? In this podcast, Tiziano Barbui starts by giving some background to the COVID-19 pandemic in...
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease 30.06.2020 24:34
During the American Association of Cancer Research (AACR) Virtual Annual Meeting I, the MPN Hub was pleased to speak to Christine Spencer, Parker Institute for Cancer Immunotherapy, San-Francisco, US and Diwakar Davar, University of Pennsylvania Medical Center, Pittsburgh, US. We asked: how can we use the microbiome to improve cancer immunotherapy and alleviate side effects such as graft- versus -...
Podcasts similaires
Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics